Votrient (pazopanib hydrochloride)

pCPA File Number: 20902
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Renal Cell Carcinoma
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: